Regenxbio Inc (RGNX)
US$ 9.16-0.43%
Price Chart
Key Statistics
Market Cap
$ 461.08M
P/E Ratio
0.00
Revenue (TTM)
$ 83.33M
Volume
601.22K
52W High
$ 17.52
52W Low
$ 5.04
Dividend Yield
0.00%
Beta
1.26
Technicals
50-Day MA
7.0106
200-Day MA
9.4228
52 Week High
17.52
52 Week Low
5.035
About RGNX
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.
Employees
353
Headquarters
Rockville, MD
CEO
Mr. Curran M. Simpson M.S.
Latest News
Is REGENXBIO (NASDAQ:RGNX) A Risky Investment? - simplywall.st
3 days ago • Google News
REGENXBIO Inc. (NASDAQ:RGNX) Is About To Turn The Corner - Yahoo Finance
2025-03-17 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg